Analyst Ratings for WuXi PharmaTech (WX)
WX Rating Summary
WX Price Target Summary
- Highest: $21.50 (Jefferies)
- Lowest: $13.00 (Credit Agricole)
- Average: $17.38
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$17.38 (-19%)
Avg. $ Target:
$17.38 (-19%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/29/2012 | Barclays | New Coverage | Overweight (N/A) |
20.00 (N/A) |
16.10 | 21.45 | 33.23% | Details |
| 9/20/2012 | Credit Suisse | New Coverage | Outperform (N/A) |
N/A (N/A) |
13.94 | 21.45 | 53.87% | Details |
| 2/6/2012 | Wells Fargo | Downgrade | Market Perform (N/A) |
15.00 (N/A) |
14.81 | 21.45 | 44.83% | Details |
| 11/11/2011 | Credit Agricole | Downgrade | Outperform (N/A) |
13.00 (N/A) |
12.08 | 21.45 | 77.57% | Details |
| 8/12/2011 | Jefferies » Updated 3/8/2013 |
Upgrade | Buy (N/A) |
21.50 (17.00) |
14.00 | 21.45 | 53.21% | Details |
| 4/25/2011 | William Blair | New Coverage | Outperform (N/A) |
N/A (N/A) |
17.07 | 21.45 | 25.66% | Details |
| 3/9/2011 | Piper Jaffray | Upgrade | Overweight (N/A) |
N/A (N/A) |
16.83 | 21.45 | 27.45% | Details |
| 11/26/2010 | Goldman Sachs | Upgrade | Buy (N/A) |
N/A (N/A) |
17.69 | 21.45 | 21.25% | Details |
| 11/18/2010 | Deutsche Bank | New Coverage | Buy (N/A) |
N/A (N/A) |
17.21 | 21.45 | 24.64% | Details |
| 11/16/2010 | JPMorgan | Upgrade | Overweight (N/A) |
N/A (N/A) |
16.84 | 21.45 | 27.38% | Details |
| 8/5/2010 | Oppenheimer | New Coverage | Outperform (N/A) |
N/A (N/A) |
15.40 | 21.45 | 39.29% | Details |
